Cancer Commons

05/12/2026

For 𝗕𝗿𝗮𝗶𝗻 𝗧𝘂𝗺𝗼𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵, you're invited to a free webinar: 𝗛𝗮𝗿𝗻𝗲𝘀𝘀𝗶𝗻𝗴 𝗢𝘅𝘆𝗴𝗲𝗻 𝘁𝗼 𝗙𝗶𝗴𝗵𝘁 𝗕𝗿𝗮𝗶𝗻 𝗧𝘂𝗺𝗼𝗿𝘀 | TODAY Tuesday, May 12 at 4pm PT | 7pm ET

Tumor hypoxia (low oxygen in the tumor environment) is a key factor in glioblastoma's resistance to treatment. This webinar explores emerging approaches to reversing hypoxia and improving the efficacy of standard of care, featuring Dr. Nicholas Blondin of Yale Medicine.

Presented by our longtime partner, the Musella Foundation For Brain Tumor Research & Information, Inc. Link to attend: virtualtrials.org/webinar

05/06/2026

We are honored to celebrate and share this wonderful post from our partner Head For The Cure. Sending gratitude every day to 𝗨𝗻𝘀𝗵𝗮 𝗕𝗮𝗸𝗸𝗲𝗿, 𝗠𝗦𝗡, 𝗥𝗡, 𝗢𝗖𝗡, 𝗖𝗕𝗖𝗡, Brain Cancer Support and Solutions Alliance Nurse Navigator at Cancer Commons.

For National Nurses Day, we are proud to feature Unsha Bakker, MSN, RN, OCN, CBCN, our Brain Cancer Support and Solutions Alliance (BCSSA) Nurse Navigator.

In collaboration with Head for the Cure, the Musella Foundation For Brain Tumor Research & Information, Inc, and Cancer Commons, Unsha plays a pivotal role in supporting the brain tumor community. With over a decade of nursing experience, she brings both expertise and compassion to help patients navigate a brain tumor diagnosis.

“I have found my calling in oncology nursing. This field has deeply impacted me and has opened my heart tenfold. The patients and loved ones I interact with each day have brought new meaning to my life,” Unsha shares.

Learn more about Unsha and our work with the BCSSA:
https://www.cancercommons.org/bcssa

04/28/2026

Here’s the latest from our Curious Dr. George! Read Cancer Commons “Seeking Patients with Advanced Cancer for a New Clinical Study” here: bit.ly/CCCDGPillai

Cancer Commons has launched a new clinical study that features drug sensitivity testing—laboratory testing of individual patients’ cancer cells to identify drugs that might work for them. Our Curious Dr. George asks Cancer Commons Director of Clinical Sciences Prajit Pillai, PhD, MBA, about the study.

12/31/2025

As the year comes to a close, we send our gratitude to the patients and caregivers, partner organizations, and donors who make our work possible.

To everyone who has already contributed, thank you. Your generosity makes a direct difference for patients and families navigating advanced cancer.

There’s still time to make a 2025 donation to help sustain this important work. We are deeply grateful for every gift, at every level of support. bit.ly/CancerCommonsGive

11/20/2025

Here’s the latest from our Curious Dr. George! Read “Morning Administration of Cancer Immunotherapy May Help Patients Live Twice as Long” here: bit.ly/CCCDGNottke2025

Could boosting the benefits of immunotherapy for cancer patients be as simple as scheduling it earlier in the day? Our Curious Dr. George asks Cancer Commons Scientist Amanda Nottke, PhD, about the latest insights into this compelling question.

11/20/2025

Here’s the latest from our Curious Dr. George! Read “How Would a Mayo Clinic Oncologist Manage His Own Mantle Cell Lymphoma?” here: bit.ly/CCCDGMunoz

Cancer patients often ask their doctors, “What would you do if you were me?” Our Curious Dr. George asks Mayo Clinic oncologist Javier Munoz, MD, MS, MBA, how he would handle his own diagnosis of mantle cell lymphoma. At the Mayo Clinic in Arizona, Dr. Munoz serves as Director of the Lymphoma Program, Co-Director of the Cellular Therapy Program, and Director of the Cancer Center Clinical Trials Office.

09/26/2025

Here’s the latest from our Curious Dr. George! Read “How Would a Mayo Clinic Oncologist Manage His Own Acute Lymphocytic Leukemia?” here: bit.ly/CCCDGLitzow

When facing a frightening new cancer diagnosis, some people ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks leukemia expert Mark R. Litzow, MD, how he would handle his own hypothetical cancer case. Dr. Litzow is Professor Emeritus in the Division of Hematology at the Mayo Clinic in Minnesota.

09/05/2025

DO YOU HAVE YOUR SIMULCAST TICKET? | Dr. George Lundberg, Cancer Commons Editor in Chief, hosts his 15th Annual Lundberg Institute Lecture, highlighting 15 years of Cancer Commons and our unique approach to helping cancer patients. Details and Registration: bit.ly/CCLundberg15th

The lecture will take place September 8 at 5:30pm PDT at Commonwealth Club World Affairs in San Francisco, with simultaneous online access available (tickets $5).

09/01/2025

YOU'RE INVITED | Dr. George Lundberg, Cancer Commons Editor in Chief, hosts his 15th Annual Lundberg Institute Lecture, highlighting 15 years of Cancer Commons and our unique approach to helping cancer patients.

The lecture will take place September 8 at 5:30pm PDT at Commonwealth Club World Affairs, with options to attend in San Francisco or online.

Details & registration: bit.ly/CCLundberg15th

08/28/2025

Here’s the latest from our Curious Dr. George! Read “New Device from Lungpacer Medical Helps Patients with Advanced Cancer” here: bit.ly/CCCDGLungpacer

People with cancer that affects their lungs may, at some point, need to go on mechanical ventilation to help them breathe. But once they no longer need ventilation, they may struggle to regain the ability to breathe on their own. After watching his son face this challenge, Doug Evans led development of a new treatment that is like a “personal trainer” to help rebuild breathing strength more rapidly. Here, our Curious Dr. George asks Doug, who is president and CEO of Lungpacer Medical, about this approach.